CoChat
Sign Up
Cited by 341Cardiac Fibrosis and RemodelingCardiovascular Function and Risk FactorsRegulation of Appetite and Obesity

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice

Open access
Barouch, Lili A., Berkowitz, Dan E., Harrison, Robert W., O’Donnell, Christopher P., Hare, Joshua M.·2003·Circulation
DOI 10.1161/01.cir.0000083716.82622.fd
Open this paper in CoChat — free accountOpen PDF

Abstract

Background— Whether left ventricular hypertrophy (LVH) in obesity results from increased hemodynamic load or altered neurohormonal signaling remains controversial. Dysregulation of leptin, a neurohormone essential to energy homeostasis, is implicated in the pathogenesis of obesity. Because leptin has cardiovascular bioactivity, we hypothesized that disruption of leptin signaling mediates the development of obesity-associated LVH. Methods and Results— We measured left ventricular (LV) wall thickness and LV mass with echocardiography in mice lacking leptin ( ob/ob , n=15) or functional receptor ( db/db , n=10) and controls at 2, 4, and 6 months of age. None of the mice had LVH at 2 months. Progressive obesity developed in ob/ob and db/db mice. At 6 months, LVH occurred in ob/ob and db/db compared with controls. We observed corresponding myocyte hypertrophy by light microscopy. To separate the direct contribution of leptin deficiency from mechanical effects of obesity, we induced weight loss in 6- to 8-month-old ob/ob mice either by leptin infusion or caloric restriction. Mice in both groups lost similar weight compared with placebo-treated controls. Leptin infusion completely reversed the increase in wall thickness with partial resolution of myocyte hypertrophy, whereas calorie-restricted mice had no decrease in wall thickness and a lesser change in myocyte size. Conclusions— Together these data show that the effect of leptin on LV remodeling is not attributable to weight loss alone, indicating that leptin has antihypertrophic effects on the heart, either directly or through a leptin-regulated neurohumoral pathway. Disruption of leptin signaling may represent a novel mechanism in LVH and related cardiovascular disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000083716.82622.fd

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 7

  1. 1997, Eur J Med Res, 2, 7
  2. 1999, Am J Physiol, 276, E443
  3. 10.1161/hyp.31.1.409 · DOI
  4. 10.1161/hyp.36.4.501 · DOI
  5. 10.1161/hyp.39.1.69 · DOI
  6. 10.1161/circ.100.21.2177 · DOI
  7. 1976, Fed Proc, 35, 1206

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Barouch, L. A., Berkowitz, D. E., Harrison, R. W., O’Donnell, C. P., & Hare, J. M.
Affiliations
  • Johns Hopkins University (US)
  • From the Department of Medicine, Divisions of Cardiology (L.A.B., R.W.H., J.M.H.) and Pulmonary Medicine (C.P.O.) and the Department of Anesthesia and Critical Care Medicine (D.E.B.), Johns Hopkins Medical Institutions, Baltimore, Md.
ORCID
Venue
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2003-08-12
Volume
108
Issue
6
Pages
754-759
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
DOI
10.1161/01.cir.0000083716.82622.fd
OpenAlex
W2119801354
Cited by
341
References
36
Citations by year
2026: 6 · 2025: 6 · 2024: 11 · 2023: 9 · 2022: 17 · 2021: 11 · 2020: 13 · 2019: 14 · 2018: 8 · 2017: 20 · 2016: 8 · 2015: 15 · 2014: 15 · 2013: 26 · 2012: 15
FWCI
11.37
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (K08HL003238, R01HL065455)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
leptin signaling, cardiac hypertrophy, left ventricular hypertrophy, obesity, leptin receptor, ob/ob mice, db/db mice, myocyte hypertrophy, cardiac remodeling, caloric restriction, weight loss, hemodynamic load
MeSH terms
Animals, Body Weight, Disease Models, Animal, Cardiomegaly, Heart Ventricles, Hemodynamics, Homozygote, Mice, Inbred C57BL, Mice, Mutant Strains, Myocardium, Obesity, Organ Size, Receptors, Cell Surface, Signal Transduction, Disease Progression, Ventricular Remodeling, Leptin, Myocytes, Cardiac, Mice, Receptors, Leptin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review